Identifying Pre-Menopausal Patients Who Do Not Need Chemotherapy Further Confirmation of the Use of EndoPredict in Young Patients Recent data from ASCO 2021 reconfirm the reliable long-term prognosis by EndoPredict. In a study of 385 pre-menopausal patients with up to three affected lymph nodes, treated with adjuvant endocrine therapy alone…
Provides Individualized Breast Cancer Risk for Patients Testing Negative with the myRisk® Hereditary Cancer Test
Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra® DA at the 2017 Annual European Congress of Rheumatology
Company to Seek FDA Approval of BRACAnalysis CDx Test in HER2- Metastatic Breast Cancer